Trial Outcomes & Findings for Home Usability Study of the SARS-CoV-2 (COVID-19) Test (NCT NCT04395391)
NCT ID: NCT04395391
Last Updated: 2023-12-13
Results Overview
The percent of samples from the fully enrolled cohort to return a valid SARS-CoV-2 test result (positive, not detected, or inconclusive)
Recruitment status
COMPLETED
Target enrollment
30 participants
Primary outcome timeframe
Subjects are assessed at enrollment
Results posted on
2023-12-13
Participant Flow
Participant milestones
| Measure |
Volunteers
Men and women who had no prior medical or laboratory training, no prior experience with COVID-19 self-collection, or no prior SARS-CoV-2 testing.
|
|---|---|
|
Overall Study
STARTED
|
30
|
|
Overall Study
COMPLETED
|
30
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
Baseline characteristics by cohort
| Measure |
Volunteers
n=30 Participants
Men and women who had no prior medical or laboratory training, no prior experience with COVID-19 self-collection, or no prior SARS-CoV-2 testing.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
30 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
26 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
30 participants
n=5 Participants
|
|
Level of Education
College degree, or higher
|
23 Participants
n=5 Participants
|
|
Level of Education
Other level of education
|
7 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Subjects are assessed at enrollmentPopulation: Each participant only completed one test.
The percent of samples from the fully enrolled cohort to return a valid SARS-CoV-2 test result (positive, not detected, or inconclusive)
Outcome measures
| Measure |
Volunteers
n=30 Participants
Men and women who had no prior medical or laboratory training, no prior experience with COVID-19 self-collection, or no prior SARS-CoV-2 testing.
|
|---|---|
|
Valid SARS-CoV-2 Test
|
30 Participants
|
Adverse Events
Volunteers
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Alexandra Massoud, Vice President of Clinical Affairs
Exact Sciences
Phone: 608-284-5700
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee Principal Investigator agreed that they shall not, without the Sponsor's prior written consent, independently publish, publicly disclose, present or discuss any results of or information pertaining to the activities conducted under their agreement for a period of one (1) year following completion of the Study.
- Publication restrictions are in place
Restriction type: OTHER